InterpretOmics to raise Series A funding in Sept

Bangalore-based InterpretOmics, a genomics data sciences company, inaugurated its Centre for Next Generation Sequencing (NGS) wet-lab in Bangalore, with an investment of Rs 3.5 crore within two-and-a-half months period


Mr Prahalad Achutharao, co-founder & CEO, InterpretOmics

The lab measures 600 sq ft in area, and houses equipments manufactured by major suppliers including Agilent, Illumina, Thermo Fisher Scientific and Millipore.

"This is a centre of excellence. We are focusing on research, development and delivery model (RDD). Our USP is in carrying out R&D along with the delivery. The centre will cater to research, clinics and as well as organizations in the pharmaceutical, biotech, and bioagri sectors," said Mr Prahalad Achutharao, co-founder & CEO, InterpretOmics.

As of now, the company is awaiting approval certifications from DSIR (Department for Scientific & Industrial Research), and NABL (National Accreditation Board for Testing and Calibration Laboratories).

The newly inaugurated centre will cater to its growing customer base in sequencing and analysis. The space also houses a bio-banking facility.

Mr Achutharao explained that usually sequencing and analysis happens with two different parties, which brings certain conflicts if there were to be any discrepancies.


Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email